DARCY TADDEO: Open Payments
NPI 1508216599 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 20 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $67 |
| CSL Behring | 2 | $51 |
| Lilly USA, LLC | 2 | $40 |
| Amgen Inc. | 2 | $39 |
| UCB, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Biogen, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| LivaNova USA, Inc. | 1 | $22 |
Products named: ULTOMIRIS, Hizentra, AMYVID, UPLIZNA, Rystiggo, AUSTEDO XR, TYSABRI, ONPATTRO.
Industry payments across KY — which companies pay providers there.
